{"transactions":[{"id":1056035,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP","position":1,"cik":"0001053369","reported_name":"ELITE PHARMACEUTICALS INC /NV/","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2025-08-26T21:17:39.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options were fully vested and exercisable as of the transaction date."}],"balance_after":2500000,"derivative":{"exercise_price":0.03,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001493152-25-012347","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225012347/ownership.xml","form_type":"4"}},{"id":1056034,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP","position":1,"cik":"0001053369","reported_name":"ELITE PHARMACEUTICALS INC /NV/","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2025-08-26T21:17:39.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":true,"shares":2500000,"price":0.03,"value":75000.0,"ownership":{"direct":true},"balance_after":4300000,"source":{"system":"sec-edgar","filing":"0001493152-25-012347","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225012347/ownership.xml","form_type":"4"}},{"id":1056033,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP","position":1,"cik":"0001053369","reported_name":"ELITE PHARMACEUTICALS INC /NV/","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2025-08-26T21:17:39.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":500000,"price":0.5243,"value":262150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4"}],"balance_after":1800000,"source":{"system":"sec-edgar","filing":"0001493152-25-012347","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225012347/ownership.xml","form_type":"4"}}]}